Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × 90 days × Clear all

NCT04748419 2026-06-05

Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07485452 2026-06-05

OSIBBBOOST

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07579221 2026-06-05

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07630077 2026-06-05

Trastuzumab Rezetecan(SHR-A1811) Combined With Ivonescimab (AK112) in Locally Advanced or Metastatic Non-small Cell Lung Cancer Harboring HER2 Gene Abnormalities

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07630168 2026-06-05

TIMED

Phase 2 Not yet recruiting

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Lung Neoplasms

NCT03774758 2026-06-04

Biomarkers for Risk Stratification in Lung Cancer

Carcinoma, Non-Small-Cell Lung, Solitary Pulmonary Nodule

NCT04297605 2026-06-04

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07626736 2026-06-04

Evaluating the Efficacy and Safety of AI Localization Models in Multidisciplinary Team Care for NSCLC

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07627321 2026-06-04

PRAD2

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT03958565 2026-06-03

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Carcinoma, Non-Small-Cell Lung

NCT04410796 2026-06-03

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05549037 2026-06-03

LungTIME-C01

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung

NCT07359040 2026-06-03

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06731413 2026-06-02

Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07619339 2026-06-02

A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07619599 2026-06-02

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Phase 1 Not yet recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07619911 2026-06-02

SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05312840 2026-06-01

Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Sintilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT05933239 2026-06-01

MAGMA

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07618793 2026-06-01

Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Pathologic Complete Response, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT01421953 2026-05-29

PULMOTEP

Phase NA Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05802186 2026-05-29

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06833229 2026-05-29

FDG Immun Comb

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06866717 2026-05-29

HYBREATH

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07608159 2026-05-29

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06566443 2026-05-28

Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07267000 2026-05-28

ImmuEX

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Motor Activity, Small Cell Lung Carcinoma

NCT07610616 2026-05-28

Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids

Carcinoma, Non-Small-Cell Lung

NCT03237377 2026-05-27

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT03392246 2026-05-27

A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07608835 2026-05-27

IMMUNOLUNG

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07609121 2026-05-27

Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06337552 2026-05-26

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Phase NA Active not recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Rectal Neoplasms

NCT06496659 2026-05-26

SAINT

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07249372 2026-05-26

DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07375316 2026-05-26

A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02186847 2026-05-22

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Phase 2 Completed

170 enrolled 19 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT03527108 2026-05-22

Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03786692 2026-05-22

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05800587 2026-05-22

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT06813664 2026-05-22

CURB-TKI

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07140315 2026-05-22

DK222 Study at Hopkins

Phase 1 Recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07355205 2026-05-22

FLINN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Phase 4 Recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07603661 2026-05-22

Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07603856 2026-05-22

REVIVE

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02696993 2026-05-20

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Phase 1/2 Active not recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04015778 2026-05-20

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04123379 2026-05-20

Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)

Phase 2 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT04588246 2026-05-20

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Phase 3 Terminated

19 enrolled 19 charts

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Small Cell Lung Carcinoma